ENO2 and small cell lung carcinoma: In small cell lung cancer (SCLC) patients, serum pro-gastrin-releasing peptide (ProGRP), neuron-specific enolase (NSE), and cytokeratin 19 fragment (CYFRA 21-1) levels closely correlated with treatment response and overall survival [383].